Robinhood Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2M Sell
72,406
-16,716
-19% -$3.6M 0.97% 19
2026
Q1
$19.4M Buy
89,122
+20,057
+29% +$4.45M 1.41% 16
2025
Q4
$15.8M Buy
+69,065
New +$15.7M 1.26% 18

Other funds holding ABBV

Robinhood Asset Management's ABBV Position: Q2 2026 in Review

Robinhood Asset Management reduced its AbbVie (ABBV) stake by 19% in Q2 2026, selling an estimated $3.6M and leaving 72,406 shares worth $18.2M. The position accounts for 0.97% of the portfolio, ranked #19.

Robinhood Asset Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $19.4M in Q1 2026. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Robinhood Asset Management held 72,406 shares of AbbVie worth $18.2M as of Q2 2026.
  • Robinhood Asset Management sold 16,716 AbbVie shares in Q2 2026, an estimated $3.6M.
  • AbbVie made up 0.97% of Robinhood Asset Management's portfolio in Q2 2026, its #19 holding.
  • Robinhood Asset Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Robinhood Asset Management's AbbVie position peaked at $19.4M in Q1 2026.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Robinhood Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.